TickerFacts.

NRC Health (NRC): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$120.89M
As of 2025-12-31
$129.60M
As of 2026-06-30
+27.4%
3-year compound annual growth
+11.8%
5-year compound annual growth
+8.4%
10-year compound annual growth
2010-12-31: $47.19M2011-12-31: $45.12M2012-12-31: $43.30M2013-12-31: $39.33M2014-12-31: $41.76M2015-12-31: $53.83M2016-12-31: $37.82M2017-12-31: $37.27M2018-12-31: $88.95M2019-12-31: $77.79M2020-12-31: $69.11M2021-12-31: $72.20M2022-12-31: $58.43M2023-12-31: $73.48M2024-12-31: $101.25M2025-12-31: $120.89M$120.89M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$120.89M+19.4%2026-03-05, Balance as of period end
2024-12-31$101.25M+37.8%2026-03-05, Balance as of period end
2023-12-31$73.48M+25.8%2025-03-17, Balance as of period end
2022-12-31$58.43M-19.1%2024-02-27, Balance as of period end
2021-12-31$72.20M+4.5%2023-03-03, Balance as of period end
2020-12-31$69.11M-11.2%2022-03-04, Balance as of period end
2019-12-31$77.79M-12.5%2021-03-05, Balance as of period end
2018-12-31$88.95M+138.6%2020-03-06, Balance as of period end
2017-12-31$37.27M-1.4%2019-03-08, Balance as of period end
2016-12-31$37.82M-29.7%2018-03-14, Balance as of period end
2015-12-31$53.83Mn/c2017-03-03, Balance as of period end
2014-12-31$41.76M+6.2%2016-03-04, Balance as of period end
2013-12-31$39.33M-9.2%2015-03-04, Balance as of period end
2012-12-31$43.30M-4.0%2014-03-04, Balance as of period end
2011-12-31$45.12M-4.4%2013-03-01, Balance as of period end
2010-12-31$47.19Mn/a2012-03-01, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
NRC Health (NRC)2025-12-31$120.89M+19.4%
MaxCyte, Inc. (MXCT)2025-12-31$31.02M-6.6%
OmniAb, Inc. (OABI)2025-12-31$33.89M-10.7%
Foxo Technologies Inc. (FOXO)2025-12-31$33.50M-8.1%
Medpace Holdings, Inc. (MEDP)2025-12-31$1.52B+18.9%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$3.68M-5.8%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.92B-2.4%
Incyte Corp (INCY)2025-12-31$1.79B-10.3%
Absci Corp (ABSI)2025-12-31$26.85M-22.1%

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗